Mitochondria are generally considered as a powerhouse in a cell where the majority of the cellular ATP and metabolite productions occur. Metabolic rewiring and reprogramming may be initiated and regulated by mitochondrial enzymes. The hypothesis that cellular metabolic rewiring and reprogramming processes may occur as cellular microenvironment is disturbed, resulting in alteration of cell phenotype, such as cancer cells resistant to therapeutics seems to be now acceptable. Cancer metabolic reprogramming regulated by mitochondrial enzymes is now one of the hallmarks of cancer. This chapter provides an overview of cancer metabolism and summarizes progress made in mitochondria-mediated metabolic regulation in cancer drug resistance.
CITATION STYLE
Pan, Y., Cao, M., Liu, J., Yang, Q., Miao, X., Go, V. L. W., … Xiao, G. G. (2017). Metabolic regulation in mitochondria and drug resistance. In Advances in Experimental Medicine and Biology (Vol. 1038, pp. 149–171). Springer New York LLC. https://doi.org/10.1007/978-981-10-6674-0_11
Mendeley helps you to discover research relevant for your work.